Pepdox
Studies
Peptides
Calculator
Incretin-Based Therapies and Heart Failure Outcomes: Benefit Beyond Weight Loss? | Pepdox
Home
/
Search
/
PMID 40903132
Incretin-Based Therapies and Heart Failure Outcomes: Benefit Beyond Weight Loss?
Journal of the American College of Cardiology
2025
PMID: 40903132
View on PubMed
DOI: 10.1016/j.jacc.2025.07.022
Semaglutide
Tirzepatide
Authors
Savarese, Gianluigi; Butler, Javed
Keywords
heart failure
incretin
obesity
semaglutide
tirzepatide